{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:37:03Z","timestamp":1787240223399,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Photochem Photobiol Sci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s43630-025-00698-8","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T01:14:21Z","timestamp":1742174061000},"page":"451-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synergic anti-tumor effects of photodynamic therapy and resveratrol on triple-negative breast cancer cells"],"prefix":"10.1007","volume":"24","author":[{"given":"Masta","family":"Ghazizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khatereh","family":"Khorsandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SMahmoud A.","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"17","key":"698_CR1","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz, S., Czeczelewski, M., Forma, A., Baj, J., Sitarz, R., & Stanis\u0142awek, A. (2021). Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014An updated review. Cancers, 13(17), 4287.","journal-title":"Cancers"},{"key":"698_CR2","doi-asserted-by":"publisher","DOI":"10.18502\/ijhoscr.v16i2.9204","author":"V Vahdanikia","year":"2022","unstructured":"Vahdanikia, V., Maleki, M., Fam, R. A. I., & Abdi, A. (2022). Assessment the effect of human umbilical cord wharton\u2019s jelly stem cells on the expression of homing genes; CXCR4 and VLA-4 in cell line of breast cancer. International Journal of Hematology-Oncology and Stem Cell Research. https:\/\/doi.org\/10.18502\/ijhoscr.v16i2.9204","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research."},{"issue":"1","key":"698_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40944-022-00648-7","volume":"21","author":"MS Maghsoodi","year":"2023","unstructured":"Maghsoodi, M. S., Khosroshahi, N. S., Beilankouhi, E. A. V., Valilo, M., & Feizi, M. A. H. (2023). VEGF-634G> C (rs2010963) gene polymorphism and high risk of breast cancer in the Northwest of Iran. Indian Journal of Gynecologic Oncology., 21(1), 6.","journal-title":"Indian Journal of Gynecologic Oncology."},{"issue":"16","key":"698_CR4","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., et al. (2004). Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clinical cancer research., 10(16), 5367\u20135374.","journal-title":"Clinical cancer research."},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"C Garrido-Castro","year":"2019","unstructured":"Garrido-Castro, C. (2019). Insights into molecular classifications of triple-negative breast cancer: Improving patient selection for treatment. Cancer Discovery, 9, 176.","journal-title":"Cancer Discovery"},{"issue":"1","key":"698_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25962-0","volume":"12","author":"D Hammerl","year":"2021","unstructured":"Hammerl, D., Martens, J. W., Timmermans, M., Smid, M., Trapman-Jansen, A. M., Foekens, R., et al. (2021). Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer. Nature communications, 12(1), 1\u201313.","journal-title":"Nature communications"},{"issue":"9","key":"698_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/cancers11091334","volume":"11","author":"K-L Lee","year":"2019","unstructured":"Lee, K.-L., Kuo, Y.-C., Ho, Y.-S., & Huang, Y.-H. (2019). Triple-negative breast cancer: Current understanding and future therapeutic breakthrough targeting cancer stemness. Cancers, 11(9), 1334.","journal-title":"Cancers"},{"issue":"15","key":"698_CR8","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., et al. (2007). Triple-negative breast cancer: Clinical features and patterns of recurrence. Clinical Cancer Research, 13(15), 4429\u20134434.","journal-title":"Clinical Cancer Research"},{"issue":"18","key":"698_CR9","doi-asserted-by":"publisher","first-page":"4132","DOI":"10.1002\/cncr.26019","volume":"117","author":"FO Ademuyiwa","year":"2011","unstructured":"Ademuyiwa, F. O., Groman, A., O\u2019Connor, T., Ambrosone, C., Watroba, N., & Edge, S. B. (2011). Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer, 117(18), 4132\u20134140.","journal-title":"Cancer"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.2147\/CMAR.S272685","volume":"12","author":"J Shi","year":"2020","unstructured":"Shi, J., Liu, F., & Song, Y. (2020). Progress: Targeted therapy, immunotherapy, and new chemotherapy strategies in advanced triple-negative breast cancer. Cancer Management and Research., 12, 9375.","journal-title":"Cancer Management and Research."},{"issue":"8","key":"698_CR11","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","volume":"13","author":"LA Carey","year":"2007","unstructured":"Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., et al. (2007). The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes. Clinical Cancer Research, 13(8), 2329\u20132334.","journal-title":"Clinical Cancer Research"},{"issue":"20","key":"698_CR12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1200\/JCO.2013.53.1608","volume":"32","author":"I Vaz-Luis","year":"2014","unstructured":"Vaz-Luis, I., Ottesen, R. A., Hughes, M. E., Mamet, R., Burstein, H. J., Edge, S. B., et al. (2014). Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: A multi-institutional study. Journal of Clinical Oncology, 32(20), 2142.","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"698_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMoa2112651","volume":"386","author":"P Schmid","year":"2022","unstructured":"Schmid, P., Cortes, J., Dent, R., Pusztai, L., McArthur, H., K\u00fcmmel, S., et al. (2022). Event-free survival with pembrolizumab in early triple-negative breast cancer. New England Journal of Medicine, 386(6), 556\u2013567.","journal-title":"New England Journal of Medicine"},{"key":"698_CR14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2019.37.15_suppl.591","author":"WM Sikov","year":"2019","unstructured":"Sikov, W. M., Polley, M.-Y., Twohy, E., Perou, C. M., Singh, B., Berry, D. A., et al. (2019). CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT)+\/-carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC). American Society of Clinical Oncology. https:\/\/doi.org\/10.1200\/JCO.2019.37.15_suppl.591","journal-title":"American Society of Clinical Oncology"},{"issue":"3","key":"698_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.32604\/biocell.2021.014439","volume":"45","author":"Z Wang","year":"2021","unstructured":"Wang, Z., Peng, H., Shi, W., Gan, L., Zhong, L., He, J., et al. (2021). Application of photodynamic therapy in cancer: Challenges and advancements. Biocell, 45(3), 489.","journal-title":"Biocell"},{"issue":"4","key":"698_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1534735404270335","volume":"3","author":"KA Conklin","year":"2004","unstructured":"Conklin, K. A. (2004). Chemotherapy-associated oxidative stress: Impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, 3(4), 294\u2013300.","journal-title":"Integrative Cancer Therapies"},{"issue":"1","key":"698_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02280-5","volume":"21","author":"M Alavi","year":"2021","unstructured":"Alavi, M., Farkhondeh, T., Aschner, M., & Samarghandian, S. (2021). Resveratrol mediates its anti-cancer effects by Nrf2 signaling pathway activation. Cancer Cell International, 21(1), 1\u20139.","journal-title":"Cancer Cell International"},{"issue":"10","key":"698_CR18","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/pharmaceutics13101562","volume":"13","author":"LM Ailioaie","year":"2021","unstructured":"Ailioaie, L. M., Ailioaie, C., & Litscher, G. (2021). Latest innovations and nanotechnologies with curcumin as a nature-inspired photosensitizer applied in the photodynamic therapy of cancer. Pharmaceutics, 13(10), 1562.","journal-title":"Pharmaceutics"},{"issue":"5","key":"698_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/phpp.12489","volume":"35","author":"RL Yanovsky","year":"2019","unstructured":"Yanovsky, R. L., Bartenstein, D. W., Rogers, G. S., Isakoff, S. J., & Chen, S. T. (2019). Photodynamic therapy for solid tumors: A review of the literature. Photodermatology, Photoimmunology & Photomedicine, 35(5), 295\u2013303.","journal-title":"Photodermatology, Photoimmunology & Photomedicine"},{"issue":"3","key":"698_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1021\/cb5009124","volume":"10","author":"T-C Cheong","year":"2015","unstructured":"Cheong, T.-C., Shin, E. P., Kwon, E.-K., Choi, J.-H., Wang, K.-K., Sharma, P., et al. (2015). Functional manipulation of dendritic cells by photoswitchable generation of intracellular reactive oxygen species. ACS Chemical Biology, 10(3), 757\u2013765.","journal-title":"ACS Chemical Biology"},{"issue":"2","key":"698_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40005-017-0377-x","volume":"48","author":"HS Hwang","year":"2018","unstructured":"Hwang, H. S., Shin, H., Han, J., & Na, K. (2018). Combination of photodynamic therapy (PDT) and anti-tumor immunity in cancer therapy. Journal of Pharmaceutical Investigation, 48(2), 143\u2013151.","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"7","key":"698_CR22","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/DSS.0000000000000800","volume":"42","author":"DM Ozog","year":"2016","unstructured":"Ozog, D. M., Rkein, A. M., Fabi, S. G., Gold, M. H., Goldman, M. P., Lowe, N. J., et al. (2016). Photodynamic therapy: A clinical consensus guide. Dermatologic Surgery, 42(7), 804\u2013827.","journal-title":"Dermatologic Surgery"},{"issue":"4","key":"698_CR23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5114\/ceji.2015.56974","volume":"40","author":"M Wachowska","year":"2015","unstructured":"Wachowska, M., Muchowicz, A., & Demkow, U. (2015). Immunological aspects of antitumor photodynamic therapy outcome. Central European Journal of Immunology, 40(4), 481\u2013485.","journal-title":"Central European Journal of Immunology"},{"issue":"10","key":"698_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/foods6100090","volume":"6","author":"A Ragusa","year":"2017","unstructured":"Ragusa, A., Centonze, C., Grasso, M. E., Latronico, M. F., Mastrangelo, P. F., Fanizzi, F. P., et al. (2017). Composition and statistical analysis of biophenols in Apulian Italian EVOOs. Foods, 6(10), 90.","journal-title":"Foods"},{"issue":"3","key":"698_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/molecules26030718","volume":"26","author":"R Guti\u00e9rrez-Escobar","year":"2021","unstructured":"Guti\u00e9rrez-Escobar, R., Alia\u00f1o-Gonz\u00e1lez, M. J., & Cantos-Villar, E. (2021). Wine polyphenol content and its influence on wine quality and properties: A review. Molecules, 26(3), 718.","journal-title":"Molecules"},{"issue":"13","key":"698_CR26","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/molecules26134021","volume":"26","author":"J Khan","year":"2021","unstructured":"Khan, J., Deb, P. K., Priya, S., Medina, K. D., Devi, R., Walode, S. G., et al. (2021). Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules, 26(13), 4021.","journal-title":"Molecules"},{"issue":"22","key":"698_CR27","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.3390\/app112211041","volume":"11","author":"A Quarta","year":"2021","unstructured":"Quarta, A., Gaballo, A., Pradhan, B., Patra, S., Jena, M., & Ragusa, A. (2021). Beneficial oxidative stress-related trans-resveratrol effects in the treatment and prevention of breast cancer. Applied Sciences, 11(22), 11041.","journal-title":"Applied Sciences"},{"issue":"1","key":"698_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/092986706775197962","volume":"13","author":"F Orallo","year":"2006","unstructured":"Orallo, F. (2006). Comparative studies of the antioxidant effects of cis-and trans-resveratrol. Current Medicinal Chemistry, 13(1), 87\u201398.","journal-title":"Current Medicinal Chemistry"},{"key":"698_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.569295","volume":"11","author":"Z-J Liang","year":"2021","unstructured":"Liang, Z.-J., Wan, Y., Zhu, D.-D., Wang, M.-X., Jiang, H.-M., Huang, D.-L., et al. (2021). Resveratrol mediates the apoptosis of triple negative breast cancer cells by reducing POLD1 expression. Frontiers in Oncology, 11, 569295.","journal-title":"Frontiers in Oncology"},{"key":"698_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren, B., Kwah, M.X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., et al. (2021). Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Letters, 515, 63\u201372.","journal-title":"Cancer Letters"},{"issue":"1","key":"698_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/nyas.13466","volume":"1403","author":"Z Jiang","year":"2017","unstructured":"Jiang, Z., Chen, K., Cheng, L., Yan, B., Qian, W., Cao, J., et al. (2017). Resveratrol and cancer treatment: Updates. Annals of the New York Academy of Sciences, 1403(1), 59\u201369.","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"17","key":"698_CR32","doi-asserted-by":"publisher","first-page":"9511","DOI":"10.3390\/ijms22179511","volume":"22","author":"D Komorowska","year":"2021","unstructured":"Komorowska, D., Gajewska, A., Hikisz, P., Bartosz, G., & Rodacka, A. (2021). Comparison of the effects of resveratrol and its derivatives on the radiation response of MCF-7 breast cancer cells. International Journal of Molecular Sciences, 22(17), 9511.","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"698_CR33","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/molecules24061103","volume":"24","author":"Y Yang","year":"2019","unstructured":"Yang, Y., Cao, J., Wei, N., Meng, D., Wang, L., Ren, G., et al. (2019). Thermal conductivity of defective graphene oxide: A molecular dynamic study. Molecules, 24(6), 1103.","journal-title":"Molecules"},{"issue":"1","key":"698_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gene.2016.06.031","volume":"590","author":"E Nicolas","year":"2016","unstructured":"Nicolas, E., Golemis, E. A., & Arora, S. (2016). POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies. Gene, 590(1), 128\u2013141.","journal-title":"Gene"},{"key":"698_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2022.102863","volume":"70","author":"M Teimouri","year":"2022","unstructured":"Teimouri, M., Homayouni-Tabrizi, M., Rajabian, A., Amiri, H., & Hosseini, H. (2022). Anti-inflammatory effects of resveratrol in patients with cardiovascular disease: A systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine, 70, 102863.","journal-title":"Complementary Therapies in Medicine"},{"issue":"7","key":"698_CR36","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.clinthera.2018.05.015","volume":"40","author":"M Koushki","year":"2018","unstructured":"Koushki, M., Dashatan, N. A., & Meshkani, R. (2018). Effect of resveratrol supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials. Clinical Therapeutics, 40(7), 1180-1192.e5.","journal-title":"Clinical Therapeutics"},{"issue":"1","key":"698_CR37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12903-024-04045-8","volume":"24","author":"MK Alam","year":"2024","unstructured":"Alam, M. K., Alqhtani, N. R., Alnufaiy, B., Alqahtani, A. S., Elsahn, N. A., Russo, D., et al. (2024). A systematic review and meta-analysis of the impact of resveratrol on oral cancer: Potential therapeutic implications. BMC Oral Health, 24(1), 412.","journal-title":"BMC Oral Health"},{"issue":"3","key":"698_CR38","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jaad.2018.10.042","volume":"80","author":"U Keyal","year":"2019","unstructured":"Keyal, U., Bhatta, A. K., Zhang, G., & Wang, X. L. (2019). Present and future perspectives of photodynamic therapy for cutaneous squamous cell carcinoma. Journal of the American Academy of Dermatology., 80(3), 765\u2013773.","journal-title":"Journal of the American Academy of Dermatology."},{"issue":"10","key":"698_CR39","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/j.1349-7006.2008.00910.x","volume":"99","author":"Y Chen","year":"2008","unstructured":"Chen, Y., Zheng, W., Li, Y., Zhong, J., Ji, J., & Shen, P. (2008). Apoptosis induced by methylene-blue-mediated photodynamic therapy in melanomas and the involvement of mitochondrial dysfunction revealed by proteomics. Cancer Science, 99(10), 2019\u20132027.","journal-title":"Cancer Science"},{"issue":"4","key":"698_CR40","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3233\/CBM-170495","volume":"21","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Liu, X., Kang, S., Liu, C., & Hao, Y. (2018). Resveratrol enhances the effects of ALA-PDT on skin squamous cells A431 through p38\/MAPK signaling pathway. Cancer Biomarkers, 21(4), 797\u2013803.","journal-title":"Cancer Biomarkers"},{"issue":"4","key":"698_CR41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1572-1000(05)00110-9","volume":"2","author":"M Wainwright","year":"2005","unstructured":"Wainwright, M. (2005). The development of phenothiazinium photosensitisers. Photodiagnosis and Photodynamic Therapy, 2(4), 263\u2013272.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"698_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pdpdt.2018.09.001","volume":"25","author":"R Belotto","year":"2019","unstructured":"Belotto, R., Santos, R. E., Tardivo, J. P., Fernandes, R., Baptista, M., Itri, R., et al. (2019). Photodynamic therapy in vulvar lymphangioma: Case report. Photodiagnosis and Photodynamic Therapy, 25, 84\u201386.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"key":"698_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pdpdt.2016.03.003","volume":"15","author":"B Obstoy","year":"2016","unstructured":"Obstoy, B., Salaun, M., Bohn, P., Veresezan, L., Sesbou\u00e9, R., & Thiberville, L. (2016). Photodynamic therapy using methylene blue in lung adenocarcinoma xenograft and hamster cheek pouch induced squamous cell carcinoma. Photodiagnosis and Photodynamic Therapy, 15, 109\u2013114.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"3","key":"698_CR44","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/ERC-13-0171","volume":"21","author":"LG Carter","year":"2014","unstructured":"Carter, L. G., D\u2019Orazio, J. A., & Pearson, K. J. (2014). Resveratrol and cancer: Focus on in vivo evidence. Endocrine-Related Cancer, 21(3), R209\u2013R225.","journal-title":"Endocrine-Related Cancer"},{"issue":"1","key":"698_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.fct.2006.07.015","volume":"45","author":"T Horn","year":"2007","unstructured":"Horn, T., Cwik, M., Morrissey, R., Kapetanovic, I., Crowell, J., Booth, T., et al. (2007). Oncogenicity evaluation of resveratrol in p53 (\u00b1)(p53 knockout) mice. Food and Chemical Toxicology, 45(1), 55\u201363.","journal-title":"Food and Chemical Toxicology"},{"issue":"8","key":"698_CR46","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/jcmm.17242","volume":"26","author":"T Li","year":"2022","unstructured":"Li, T., Zhang, X., Cheng, L., Li, C., Wu, Z., Luo, Y., et al. (2022). Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress. Journal of Cellular and Molecular Medicine, 26(8), 2205\u20132217.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"10","key":"698_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205918","volume":"13","author":"L Peng","year":"2018","unstructured":"Peng, L., & Jiang, D. (2018). Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition. PLoS ONE, 13(10), e0205918.","journal-title":"PLoS ONE"},{"issue":"2","key":"698_CR48","first-page":"165","volume":"95","author":"I-P Laszl\u00f3","year":"2022","unstructured":"Laszl\u00f3, I.-P., Laszl\u00f3, M. R., Popescu, T., Toma, V., Ion, R. M., Moldovan, R., et al. (2022). The comparative effects of Resveratrol and Curcumin in combination with photodynamic therapy. Medicine and Pharmacy Reports, 95(2), 165.","journal-title":"Medicine and Pharmacy Reports"},{"key":"698_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2020.101656","volume":"30","author":"I-P Laszlo","year":"2020","unstructured":"Laszlo, I.-P., Laszlo, M. R., Toma, V., Baldea, I., Olteanu, D., David, L., et al. (2020). The in vivo modulatory effects of Cornus mas extract on photodynamic therapy in experimental tumors. Photodiagnosis and Photodynamic Therapy, 30, 101656.","journal-title":"Photodiagnosis and Photodynamic Therapy"},{"issue":"11","key":"698_CR50","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1039\/d0pp00132e","volume":"19","author":"AY Sadeghloo","year":"2020","unstructured":"Sadeghloo, A. Y., Khorsandi, K., & Kianmehr, Z. (2020). Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells. Photochemical & Photobiological Sciences, 19(11), 1580\u20131589.","journal-title":"Photochemical & Photobiological Sciences"},{"issue":"1","key":"698_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2010.05842.x","volume":"1215","author":"T Walle","year":"2011","unstructured":"Walle, T. (2011). Bioavailability of resveratrol. Annals of the new York Academy of Sciences, 1215(1), 9\u201315.","journal-title":"Annals of the new York Academy of Sciences"},{"issue":"2","key":"698_CR52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3390\/w14020242","volume":"14","author":"I Khan","year":"2022","unstructured":"Khan, I., Saeed, K., Zekker, I., Zhang, B., Hendi, A. H., Ahmad, A., et al. (2022). Review on methylene blue: Its properties, uses, toxicity and photodegradation. Water, 14(2), 242.","journal-title":"Water"}],"container-title":["Photochemical & Photobiological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-025-00698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43630-025-00698-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43630-025-00698-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T07:03:22Z","timestamp":1743923002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43630-025-00698-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1007\/s43630-025-00698-8","relation":{},"ISSN":["1474-905X","1474-9092"],"issn-type":[{"value":"1474-905X","type":"print"},{"value":"1474-9092","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}